J&J Joins Enlight Effort

Enlight Biosciences LLC, a Boston-based developer of technologies and strategies for “fundamentally transforming drug discovery and development,” said that Johnson & Johnson has joined its list of strategic investors. It also said that its total funding now totals $52 million. Enlight had previously disclosed $39 million in funding, from Puretech Ventures, Pfizer, Merck & Co. and Eli Lilly & Co.